Additionally, CANA treatment mitigated adenine-induced CKD in rats, and improved antioxidant enzymes such as SOD, CAT and glutathione reductase (GR) and total antioxidant activity in renal tissue homogenate [134]. The gene discussed is GSR; the disease is chronic kidney disease.